| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/18/2002 | EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 12/18/2002 | EP1265889A1 Medicaments against viral diseases |
| 12/18/2002 | EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 12/18/2002 | EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 12/18/2002 | EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 12/18/2002 | EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/18/2002 | EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 12/18/2002 | EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265853A1 Carboxylic acid derivatives as ip antagonists |
| 12/18/2002 | EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 12/18/2002 | EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 12/18/2002 | EP1265839A1 Compounds active at the glucocorticoid receptor |
| 12/18/2002 | EP1265648A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such |
| 12/18/2002 | EP1265638A1 Compositions for transdermal and transmucosal administration of therapeutic agents |
| 12/18/2002 | EP1265633A2 Adjuvant for vaccines |
| 12/18/2002 | EP1265630A2 Use of insulin for the treatment of cartilagenous disorders |
| 12/18/2002 | EP1265624A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 12/18/2002 | EP1265622A2 Treatment of herpes infection using immunomodulatory polynucleotide sequences |
| 12/18/2002 | EP1265616A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 12/18/2002 | EP1265608A2 Oxazolidinone tablet formulation |
| 12/18/2002 | EP1265606A1 Cell adhesion inhibitors |
| 12/18/2002 | EP1265603A2 Il-8 receptor antagonists |
| 12/18/2002 | EP1265599A1 Antibiotic composition with inhibitor |
| 12/18/2002 | EP1265598A1 Pharmaceutical composition for application to mucosal surfaces |
| 12/18/2002 | EP1265579A1 Container for linezolid intravenous solution |
| 12/18/2002 | EP1104420B1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 12/18/2002 | EP1098898B1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate |
| 12/18/2002 | EP1086101B1 Beta-carboline compounds |
| 12/18/2002 | EP1064273B1 1,3,4-thiadiazoles useful for the treatment of cmv infections |
| 12/18/2002 | EP1023062B1 Antibacterial carbapenems, compositions and methods of treatment |
| 12/18/2002 | EP1021180B1 Mixed cyanoacrylate ester compositions |
| 12/18/2002 | EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors |
| 12/18/2002 | EP0938331B1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 12/18/2002 | EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/18/2002 | EP0898477B1 Topical administration of premafloxacin for the treatment of systemic bacterial diseases |
| 12/18/2002 | EP0869949B1 Benzoxazine antimicrobial agents |
| 12/18/2002 | EP0866803B1 Transferrin receptor protein of moraxella |
| 12/18/2002 | EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 12/18/2002 | EP0784485B1 VACCINE COMPOSITIONS containing partially deacetylated chitin |
| 12/18/2002 | EP0769018B1 Helicobacter proteins and vaccines |
| 12/18/2002 | EP0726944B1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 12/18/2002 | EP0725783B1 2-(pyrazol-3-yl)carbapenem derivatives |
| 12/18/2002 | EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/18/2002 | EP0650357B1 Rapamycin derivatives |
| 12/18/2002 | EP0555370B1 Methods and applications for efficient genetic suppressor elements |
| 12/18/2002 | CN1386132A Antimicrobial composition |
| 12/18/2002 | CN1385440A Protein molecule with function for inhibiting I type simple herpesvirus replication and its preparation method |
| 12/18/2002 | CN1385212A Medicine for treating chickenpest |
| 12/18/2002 | CN1385211A Chinese medicine for treating heaptitis B and preparation method thereof and use of charred human hair |
| 12/18/2002 | CN1385208A Fujingwan pill for curing dermatosis |
| 12/18/2002 | CN1385205A Soft-extract for treating hepatitis B and preparation process thereof |
| 12/18/2002 | CN1385203A Compound Chinese medicine preparation of damnacanthus |
| 12/18/2002 | CN1385199A Compound phellodendron bark ringworm-removing liniment |
| 12/18/2002 | CN1385193A Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration |
| 12/18/2002 | CN1385191A Medicine for treating liver disease |
| 12/18/2002 | CN1385190A Medicine for treating liver disease |
| 12/18/2002 | CN1385176A Medicine for treating difficult pulmonary tuberculosis |
| 12/18/2002 | CN1385165A Ribavirin aerosol inhalation solution |
| 12/18/2002 | CN1385164A Sow-released roxithromycin capsule and method for preparing same |
| 12/18/2002 | CN1385160A Medicine for treating pelvia inflammation |
| 12/18/2002 | CN1385147A Nano calamine and preparation method and use thereof |
| 12/18/2002 | CN1096266C Composite antiseptic medicine |
| 12/17/2002 | US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine |
| 12/17/2002 | US6495683 Herpes virus |
| 12/17/2002 | US6495677 Nucleoside compounds |
| 12/17/2002 | US6495675 Pharmaceutical composition for treating or preventing influenza, and novel capped oligonucleotide |
| 12/17/2002 | US6495608 Methods of performing surgery with galactomannan polymers and borate |
| 12/17/2002 | US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine |
| 12/17/2002 | US6495604 Cycloalkene derivatives, process for producing the same, and use |
| 12/17/2002 | US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 12/17/2002 | US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 12/17/2002 | US6495567 Triaryl methane compounds and their use in the treatment of diarrhea and scours |
| 12/17/2002 | US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 12/17/2002 | US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth |
| 12/17/2002 | US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 12/17/2002 | US6495551 Substituted phenyloxazolidinones and their use as antibiotics |
| 12/17/2002 | US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 12/17/2002 | US6495539 Such as 6-benzoyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ethyl ester; treating gramnegative drug resistant bacterial infection |
| 12/17/2002 | US6495533 Drugs containing phosphoric acid derivatives as the active ingredient |
| 12/17/2002 | US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 12/17/2002 | US6495518 Method for importing biologically active molecules into cells |
| 12/17/2002 | US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein |
| 12/17/2002 | US6495361 Method of producing infectious papillomavirus in placental cells |
| 12/17/2002 | US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting |
| 12/17/2002 | US6495345 Surface antigen |
| 12/17/2002 | US6495332 Methods and compositions for ameliorating the symptoms of sepsis |
| 12/17/2002 | US6495157 Starage stable suppositories comprising antibiotics in form of drug particles dispersed in fats used for treatment of urogenital disorders |
| 12/17/2002 | US6495153 Anti-fungal composition |
| 12/17/2002 | US6495144 A peptide having substantial homology with the cbf1/rbpjk (cell binding factor-1/recombination bining protein j kappa) interaction domain of ebna2 comprising specific peptide containing 15-20 amino acids |
| 12/17/2002 | US6495138 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 12/17/2002 | US6495128 Human chemokine β-7 deletion and substitution proteins |
| 12/17/2002 | CA2271622C Antiviral agents from plant extracts and use for treatment of viral infections |
| 12/17/2002 | CA2069153C Pharmaceutical composition |
| 12/17/2002 | CA2068957C Pharmaceutical composition |
| 12/17/2002 | CA2052745C Process for the preparation of carnosic acid and the use of the acid for its anticarcinogenic and antiviral properties |
| 12/15/2002 | CA2390327A1 Method |
| 12/14/2002 | CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators |
| 12/13/2002 | WO2001096575A1 Ceramide kinase and dna encoding the same |